Cincinnati startup files for IPO, quietly moves headquarters

A biopharmaceutical startup with Cincinnati roots is making plans to go public with an initial offering that could top $180 million, months after inking a nine-figure fundraise that stands as one of the region’s largest.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.